Scope

The scope of this journal is extended to the researchers working as pharmacists, chemists, chemical engineers, biologists, oncologists working in R&D of drugs and biologics, scientists working in pharmacological engineering and biotechnology. It implements multi-disciplinary fields, GDDDR is publishing the review articles in the following domains;

• Medicinal Chemistry

• Structural or molecular biological studies elucidating molecular recognition processes.
• Fragment-based drug discovery.
• Drug target identification and validation.

• Pharmaceutical Technology

• Design, synthesis, and biological evaluation of novel biologically active compounds.
• Phenotypic screening and target deconvolution.

• Preclinical and Clinical Pharmacology

• Preclinical development studies.
• Translational animal models.
• Mechanisms of action and signaling pathways.
• Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development.
• Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing).

• Pharmacognosy

• Isolation, structural characterization, biosynthesis, bioengineering and pharmacological evaluation of natural products.

• Bioinformatics

• In Silico drug designing.
• Identifying targets for drug discovery using bioinformatics.
• Computer-aided drug designing

• Biotechnology

• Use of fluorescent probe for fast and quantitative detection of chemicals in blood
• genomics-based drug design and discovery

• Clinical Practice

• Pharmaceutical formulation science: is covered in detail,  with a focus on dosage form development and design,  stability investigations, and formulation techniques that  increase drug bioavailability and patient compliance.

• Clinical Pharmacokinetics: This field of study focuses on  the pharmacokinetics of medications administered via  various delivery systems. It examines the factors that affect drug distribution, metabolism, and elimination, with particular attention to how these  aspects relate to clinical outcomes.

• Cover a wide range of therapeutic areas, including  oncology, neurology, cardiology, and infectious illnesses, and explain how advances in drug delivery technologies  are increasing therapy options in each area.

• Address the unique requirements of pediatric and elderly patients, with an emphasis on age-appropriate drug administration methods, dosages, and safety considerations.
• Drug-Drug Interactions: Examine possible drug-drug interactions that might result from intricate drug delivery systems, providing guidance on how to manage polypharmacy and reduce unfavorable effects.
• Publish studies on the biopharmaceutical elements of drugs delivery, including as drug solubility, permeability, and formulation techniques to address absorption issues.
• Keep readers informed on cutting-edge drug delivery breakthroughs, including 3D printing, implantable technology, and gene delivery systems.
• Articles on methods for educating patients and healthcare professionals about drug delivery systems should be included in the section on patient education and  counselling to help patients understand their medications and adhere to them.

• Safety and toxicology: Discuss potential toxicity, side  effects, and ways to improve safety profiles as they relate  to drug delivery systems.

• Reflect a worldwide perspective by including studies and  reviews from other countries, encouraging the sharing of  knowledge and best practices in clinical pharmacy practice.
• Drug Design and Molecular Insights: Emphasise papers  that connect drug design principles with drug delivery  strategies, illuminating the molecular underpinnings of drug interactions and therapeutic mechanisms.